OUTLOOK THERAPEUTICS INC (OTLK) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.43
• Market Cap: $32.32M
• EPS: $-2.89
• 52-Week High: $3.39
• 52-Week Low: $0.38

Market Sentiment

OUTLOOK THERAPEUTICS INC currently has a Neutral sentiment score of 0.00.

About OUTLOOK THERAPEUTICS INC

Outlook Therapeutics, Inc. is a late-stage biopharmaceutical firm based in Cranbury, New Jersey, dedicated to the development of pioneering monoclonal antibody therapies aimed at treating ocular diseases. The company focuses on addressing significant unmet medical needs within the ophthalmology field, with a robust pipeline targeting critical retinal conditions. As it advances towards regulatory approvals and potential commercialization, Outlook Therapeutics is well-positioned to enhance pati...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for OUTLOOK THERAPEUTICS INC and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does OTLK pay dividends?

OUTLOOK THERAPEUTICS INC (OTLK) does not currently pay a regular dividend.

What is OTLK's market cap?

OUTLOOK THERAPEUTICS INC (OTLK) has a market capitalization of $32.32M with a current stock price of $0.43.